Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

From Distilling to Fulfilling

Christina Lake Cannabis Produces First Ultra-High Potency Distillates and Commences Marketing to CPG Industry Christina Lake Cannabis Corp. ( CSE:CLC ) (FRANKFURT: CLB) is beginning to produce ultra-high potency cannabis distillate oils from its 32,500 kg / 71,650 lb har...
Featured Submission | January 14, 2021 |

Meet the plant-based food company that’s set for success

Welcome to the Market Herald Video Q&A Podcast. I’m Brieanna McCutcheon. Most people, if not everyone, know someone vegan, vegetarian, or flexitarian. This is good news for companies like Naturally Splendid, which aim to provide tasty and delicious...
Brieanna McCutcheon | September 23, 2022 |

Will the 2020s Be Good or Bad for the Gold Market?

2010s have certainly been a roller coaster ride for gold. Will the 2020s then be better than the prior years for the yellow metal? Today’s article provides the macroeconomic outlook for the full decade – learn whether the fundamental factors will become in the ...
Arkadiusz Sieron | February 14, 2020 |

BARDA Award Provides 'Lift-off for Biotech's COVID Vaccine'

The ways in which Moderna is to use the funds are explained and an update on its coronavirus vaccine is provided in a ROTH Capital Partners report. In an April 19 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that the Biomedical Advanc...
Streetwise Reports | April 23, 2020 |

BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

The importance of health has not been as clear for a long time as it was in 2020. Detached from the discussion about the specifics of COVID-19 on mortality compared to other viruses, the need for protection is great and helplessness without a medical response is harmful to the...
Mario Hose | July 29, 2020 |

Buzz on the Bullboards: Key Goals Behind Top Investor’s Moves

(Image via HEXO Corp.) At Stockhouse, investor focus is on companies whose valuations seem a little more firmly rooted in down on planet Earth. When it comes to the most popular stocks over the previous week, three names are dominating, especially where health care ...
Stockhouse Editorial | September 22, 2021 |

Buzz on the Bullboards: Hot Summer Stocks Ahead of the Autumn Rush

(Image via Bombardier Inc.) Investors, our audience, and even some executives regularly visit this site to see how their companies and investing strategies are faring in the community. This week, our highlights go to the newer (and returning) companies that have...
Stockhouse Editorial | September 1, 2021 |

Electromed Earnings Spark a 25% Increase in Its Share Price

Shares of SmartVest maker Electromed traded 25% higher today after the firm reported Q1/20 earnings. The firm's shares set a 52-week high price after reporting a 14.1% increase in year-over-year quarterly revenue and a six-fold increase in net income per share. Develo...
Streetwise Reports | November 14, 2019 |

FDA Approval of Peanut Allergy Treatment Expected Next Year

The current status, catalysts and outlook for the immunotherapy are discussed in a ROTH Capital Partners report. In a Nov. 7 research note, ROTH Capital Partners analyst Zegbeh Jallah reported that with respect to Aimmune Therapeutics Inc. (AIMT:NASDAQ) , "all eyes r...
Streetwise Reports | November 14, 2019 |

Clinical Program Started for Agitation with Schizophrenia, Bipolar Disorder

The design of and an opinion on the included studies are provided in an H.C. Wainwright & Co. report. In a Dec. 30 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that BioXcel Therapeutics Inc. (BTAI:NASDAQ) launched its pivotal trial program for...
Streetwise Reports | January 6, 2020 |
1 2 3